A Phase 2 Study of Velcade™ in Subjects With Relapsed or Refractory Follicular B-Cell Lymphoma
This study has been terminated.
(An arm closed due to lack of efficacy)
Sponsor:
Lymphoma Study Association
Collaborator:
Janssen-Cilag International NV
Information provided by:
Lymphoma Study Association
ClinicalTrials.gov Identifier:
NCT00136591
First received: August 26, 2005
Last updated: October 22, 2010
Last verified: October 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | January 2010 |
| Primary Completion Date: | January 2010 (Final data collection date for primary outcome measure) |